McKesson Corp (MCK) stock
MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3027% above fair value
$1069.43+7.27 (+0.68%)
Close on Nov 20, 2026Market cap $124.69BP/E 28.6Yield 0.30%
McKesson gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
McKesson's gross profit for the twelve months ending Jun 30, 2026 was $14.96B, up 11.2% year over year. For fiscal 2026 it was $14.55B, up 9.2% from the year before. Over ten years it grew 2.5% a year on average. The highest annual figure on record is $14.55B in fiscal 2026.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $14.55B | +9.2% |
| FY2025 | Mar 31, 2025 | $13.32B | +3.9% |
| FY2024 | Mar 31, 2024 | $12.83B | +3.8% |
| FY2023 | Mar 31, 2023 | $12.36B | -5.9% |
| FY2022 | Mar 31, 2022 | $13.13B | +8.1% |
| FY2021 | Mar 31, 2021 | $12.15B | +1.0% |
| FY2020 | Mar 31, 2020 | $12.02B | +2.3% |
| FY2019 | Mar 31, 2019 | $11.75B | +5.1% |
| FY2018 | Mar 31, 2018 | $11.18B | -0.8% |
| FY2017 | Mar 31, 2017 | $11.27B | -1.3% |
| FY2016 | Mar 31, 2016 | $11.42B | +0.0% |
| FY2015 | Mar 31, 2015 | $11.41B | +36.6% |
| FY2014 | Mar 31, 2014 | $8.35B | +21.4% |
| FY2013 | Mar 31, 2013 | $6.88B | +7.5% |
| FY2012 | Mar 31, 2012 | $6.40B | +7.2% |
| FY2011 | Mar 31, 2011 | $5.97B | +5.2% |
| FY2010 | Mar 31, 2010 | $5.68B | +5.5% |
| FY2009 | Mar 31, 2009 | $5.38B | +7.4% |
| FY2008 | Mar 31, 2008 | $5.01B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $3.69B | +12.4% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $4.04B | +11.1% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $3.69B | +12.2% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $3.54B | +9.1% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $3.28B | +4.0% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $3.64B | +1.5% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $3.28B | +4.2% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $3.25B | +5.8% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $3.15B | +4.3% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $3.59B | +16.9% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $3.15B | -0.7% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $3.07B | -0.8% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $3.02B | -0.0% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $3.07B | -7.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $3.17B | -7.4% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $3.10B | -7.7% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $3.02B | -0.3% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $3.32B | +0.6% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $3.43B | +8.8% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $3.35B | +11.7% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $3.03B | +12.3% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $3.30B | -1.2% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $3.15B | +3.9% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $3.00B | +4.6% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $2.70B | -3.1% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $3.34B | +4.2% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $3.03B | +2.1% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $2.87B | +2.2% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $2.79B | +0.3% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $3.20B | +4.1% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $2.97B | +9.4% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $2.80B | -1.1% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $2.78B | +8.6% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $3.08B | +10.0% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $2.72B | -3.4% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $2.83B | +2.8% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $2.56B | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $2.80B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $2.81B | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $2.76B | – |
See a number that looks wrong?